Parkinson's

Digital

ECG data and AI will fuel pharma’s next drug development and...

Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.

R&D

JP Morgan 2024 – Gene Kinney

Back at JP Morgan 2024, editor-in-chief Jonah Comstock caught u

News

Closeup of X-ray photography of human brain

NRG announces £16m Series A for IND for Parkinson’s and ALS

A £16 million Series A financing – led by Omega Funds – has been announced by the innovative neuroscience company

Videos

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical.

Events

Partner Content

2nd Gene Therapy for Neurological Disorders Europe

Maximising the Opportunity in CNS Gene Therapies

News

Illustration of a nerve cell on a colored background with light effects

Competition for Neurocrine as Gocovri picks up new Parkinson...

Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with Parkinson’s disease experiencing ‘off’ episodes.